Powered by
Modality-Agnostic
Targeted Oncology
Creating new standards of care for patients with cancer
A Robust And
Diversified Pipeline
We take a unique approach to research and development–by identifying high-impact targets and then pursuing the best modality, resulting in a robust and diverse pipeline.
Leveraging the Best Scientific Collaborations
Embedding external collaboration into our research model helps advance new ideas that have a higher chance of benefiting patients. Using our own discovery efforts and exceptional engagement with academic and industry partners, we find promising clinic-ready cancer therapies.
Innovation Without Borders
With patient benefit as our priority, we leverage our scientific excellence in small molecules and biologics to create differentiated ideas, identify unique targets, and select the optimal modality to develop transformative therapeutics across cancer indications.
Cullinan Oncology
In The News
Read the latest news and information from Cullinan Oncology.
Join Our
Growing Team
Collaboration is key to how we work at Cullinan Oncology. The closer we work together—across teams, programs, backgrounds and experiences—the better we can challenge the status quo.